# Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life

> **NCT01749644** · — · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Alteration in Quality of Life of CF Patients, Following Change of Treatment From Antibiotic Inhalation to Antibiotic Inhaler

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01749644
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-06
- **Final completion:** 2015-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01749644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01749644, "Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01749644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*